COVID-19 Public Company Disclosure Insights
© 2020 King & Spalding LLP Contact Us Disclaimer Privacy Notice Cookie Policy Copyright Notice Regulatory Notices
K&S Coronavirus Insights & Resources
K&S Coronavirus Disclosure Taskforce is actively tracking key disclosure-related issues facing public companies, monitoring relevant SEC filings and other market-facing communications each day to provide practical and concise market intelligence. Below are some of the key topics we are tracking, as well as the team members you can reach out to for additional information and discussion.
An up-to-date summary of the SEC’s published filing relief and disclosure guidance on COVID-19 related issues
READ MORE
Item 2.03 8-K Obligations
Past Topics
Virtual Annual Shareholder Meetings
SEC Guidance and Filing Relief
Coronavirus Disclosure Taskforce
Keith Townsend
VIEW BIO
Keith Townsend
Partner
Partner
Atlanta
+1 404 572 3517
ktownsend@kslaw.com
Cal Smith
Partner
Cal Smith
VIEW BIO
Partner
Atlanta
+1 404 572 4875
calsmith@kslaw.com
Craig Garvey
Partner
Craig Garvey
VIEW BIO
Partner
Chicago
+1 312 764 6930
cgarvey@kslaw.com
Dixie Johnson
Partner
Dixie Johnson
VIEW BIO
Partner
Washington, D.C.
+1 202 626 8984
djohnson@kslaw.com
Richard Fields
Director, Corp. Stakeholder Engagement
Richard Fields
VIEW BIO
Director, Corp. Stakeholder Engagement
New York
+1 212 556 2134
rfields@kslaw.com
Rob Leclerc
Partner
Rob Leclerc
VIEW BIO
Partner
Atlanta
+1 404 572 2781
rleclerc@kslaw.com
Elizabeth Morgan
Partner
Elizabeth Morgan
VIEW BIO
Partner
New York
+1 212 556 2351
emorgan@kslaw.com
Jeff Stein
Partner
Jeff Stein
VIEW BIO
Partner
Atlanta
+1 404 572 4729
jstein@kslaw.com
Zach Cochran
Partner
Zach Cochran
VIEW BIO
Partner
Atlanta
+1 404 572 2784
zcochran@kslaw.com
Spencer Johnson
Partner
Spencer Johnson
VIEW BIO
Partner
Atlanta
+1 404 572 2765
csjohnson@kslaw.com
Risk Factor Disclosures
A synopsis of COVID-19-related risk factors
READ MORE
Zachary Davis
Associate
Zachary Davis
VIEW BIO
Associate
Atlanta
+1 404 572 2770
zdavis@kslaw.com
Virtual Annual Shareholder Meetings
READ MORE
READ MORE
Shareholder Rights Plan Activity
Shareholder Rights Plan Activity
Changes in Earning Guidance Trends
Changes in Earning Guidance Trends
K&S Coronavirus Insights & Resources
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
Financing Agreement Amendment Activity
A compilation of credit facility amendments made in connection with COVID-19, including terms, fees and links to the applicable filing
READ MORE
READ MORE
Return to Work Disclosures
A compilation of return-to-work related disclosures
READ MORE
READ MORE
Item 2.03 8-K Obligations
Amy Peters
Partner
Amy Peters
VIEW BIO
Partner
Chicago
+1 312 764 6914 apeters@kslaw.com
Past Topics
Virtual Annual Shareholder Meetings